Table 1. Mean salivary oxytocin levels (pg/ml) and standard deviations (SD) across the groups and measurement moments.

Test day	Measurement	Placebo group	Oxytocin administration group	Conditioned oxytocin group
Screening	Baseline	12.57 (SD = 12.62, n = 30)	9.66 (SD = 6.66, n = 25)	15.32 (SD = 20.08, n = 26)
Evocation day 1	Baseline	16.94 (SD = 19.64, n = 30)	12.21 (SD = 7.05, n = 26)	11.68 (SD = 8.97, n = 28)
	+ 5 minutes	14.85 (SD = 7.65, n = 30)	1912.79 (SD = 2429.66, n = 25)	28.34 (SD = 44.63, n = 28)
	+ 20 minutes	13.77 (SD = 8.47, n = 30)	1020.81 (SD = 1860.49, n = 25)	20.17 (SD = 28.76, n = 28)
	+ 50 minutes	10.18 (SD = 5.1, n = 30)	848.15 (SD = 1569.4, n = 26)	21.17 (SD = 25.99, n = 28)
Evocation day 2	Baseline	13.23 (SD = 8, n = 30)	13.01 (SD = 9.32, n = 27)	13.24 (SD = 7.12, n = 28)
	+ 5 minutes	13.97 (SD = 6.6, n = 30)	1727.86 (SD = 2272.05, n = 25)	30.89 (SD = 70, n = 28)
	+ 20 minutes	13.14 (SD = 5.62, n = 30)	1102.87 (SD = 1650.52, n = 25)	17.36 (SD = 15.37, n = 28)
	+ 50 minutes	11.08 (SD = 5.66, n = 30)	826.88 (SD = 1666.11, n = 26)	10.14 (SD = 7.55, n = 28)
Evocation day 3	Baseline	16.85 (SD = 21.56, n = 30)	14.84 (SD = 13.6, n = 26)	12.14 (SD = 12.91, n = 28)
	+ 5 minutes	12.19 (SD = 7.49, n = 30)	1719.83 (SD = 2639.64, n = 24)	20.24 (SD = 43.93, n = 27)